AP, through reporter Janet McConnaughey, reports:
Monday, Dr. Gregory Curfman, executive editor of the New England Journal of Medicine, [testified that] there had been a connection between the first federal Vioxx trial in Houston and the timing of his journal's publication of an editorial critical of a study used as evidence in that trial, reversing earlier statements.
Curfman was apparently more constrained to tell the truth when he was under oath; his earlier misstatements about the editorial's timing misled the press in its original coverage of the editorial. I think we can guess whether the restatement will get the same level of publicity. Elsewhere in Vioxx litigation:
- Merck begins presenting is defense in the Irvin case in the MDL in New Orleans today.
- In New Jersey, Merck filed a motion against the "Frankenstein's monster" of a consolidated trial of two plaintiffs whose Vioxx injury was seventeen months apart. (AP, Feb. 14).
- In Starr County, the first witness in the Garza case (Jan. 26, Jan. 28) continues her testimony today after a two and a half week break in the trial. (Britney Booth, "Starr County Vioxx trial to continue Tuesday", The Monitor, Feb. 13).